"Snorkeling" for missing players in cancer

Insights

Small nucleolar RNAs (snoRNAs) are a new cancer gene class. ACA11, an orphan snoRNA, is overexpressed in multiple myeloma due to a chromosomal translocation, impacting cancer growth and treatment resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Small nucleolar RNAs (snoRNAs) are increasingly recognized as critical regulators in cancer development.
  • Orphan snoRNAs, distinct from those linked to ribosomal proteins, play roles in gene splicing or act as microRNA precursors.
  • Aberrant gene expression is a hallmark of cancer, driving neoplastic progression.

Discussion:

  • Chu et al. identify ACA11, an orphan snoRNA within the WHSC1 gene, as significantly overexpressed in t(4;14)-positive multiple myeloma (MM).
  • This overexpression is a direct consequence of the chromosomal translocation, a known driver in hematopoietic malignancies.
  • The study links ACA11 to key MM pathobiological features, including cellular growth, chemotherapy resistance, and oxidative stress responses.

Key Insights:

  • First identification of a snoRNA overexpressed due to a chromosomal translocation in cancer.
  • ACA11's role in multiple myeloma pathogenesis, affecting growth, drug resistance, and oxidative stress.
  • Highlights the significance of orphan snoRNAs in cancer, particularly those driven by chromosomal abnormalities.

Outlook:

  • Further investigation into ACA11 as a potential therapeutic target in multiple myeloma.
  • Exploring the broader role of snoRNA deregulation in cancers associated with chromosomal translocations.
  • Potential for diagnostic or prognostic biomarkers based on snoRNA expression profiles in hematologic cancers.